|
|
 |
| |
 |
| Evolution of Stem Cell Research at CHA BIOTECH |
| 1984 |
|
- Opening of Seoul CHA Fertility Center, Korea
|
| 1988 |
|
- World's first successful pregnancy from in vitro culture of
immature oocytes
|
| 1998 |
|
- Developed vitrification method for oocyte freezing
|
| 1999 |
|
- hES cell lines established
|
| 2000 |
|
- CHA BIOTECH CO, LTD established
- World's first baby born from embryo transfer-derived vitrified- thawed human oocytes using EM grid
|
| 2001 |
|
- hES cell lines (CHA-hES1, CHA-hES2) registered with NIH
- Cell & Gene Therapy Research Institute established (merged into CSCI in 2006)
- 1st Seoul International Stem Cell Symposium sponsored by CHA Biotech
- Succeeded in neural differentiation from human embryonic stem cells and transplantation into mouse brain
|
| 2002 |
|
- Opening of Los Angeles CHA Fertility Center, USA
- Recipient of Korea's first national stem cell research grant of
US$1.2 million
- First in USA to establish commercial oocyte bank
- CHA BIOTECH CEO Hyung Min Chung recognized as Korea's Excellent Scientist of the Year in 2002 by Donga Newspaper CHA BIOTECH recognized as Excellent Venture Business by Korea's Small & Medium Business Administration
|
| 2003 |
|
-
CHA i-Cord established
- 2nd Seoul International Stem Cell Symposium sponsored by CHA Biotech
- World's first development of uterine cervix cancer diagnosis kit (Albioamp-p1)
- World's first production of haploid male germ cells from germline stem cells
|
| 2004 |
|
- Acquisition of Hollywood Presbyterian Medical Center, USA
- World's first identification of tumor suppressor gene mHAUSP
|
| 2005 |
|
-
Korea's first successful treatment of adult leukemia patient using one unit of umbilical cord blood
|
| 2006 |
|
- World's first successful treatment of urinary incontinence patient using umbilical cord blood
- Ground-breaking for new dedicated CHA Stem Cell Institute
(CSCI) research facility
- Opening of CSCI's GMP (Good Manufacturing Practice) facility
|
|
| |
|
|
|
|
